Jonathan B Bricker1, Terry Bush2, Susan M Zbikowski2, Laina D Mercer3, Jaimee L Heffner3. 1. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Psychology, University of Washington, Seattle, WA; jbricker@fhcrc.org. 2. Alere Wellbeing, Seattle, WA. 3. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA;
Abstract
OBJECTIVE: We conducted a pilot randomized trial of telephone-delivered acceptance and commitment therapy (ACT) versus cognitive behavioral therapy (CBT) for smoking cessation. METHOD:Participants were 121 uninsured South Carolina State Quitline callers who were adult smokers (at least 10 cigarettes/day) and who wanted to quit within the next 30 days. Participants were randomized to 5 sessions of either ACT or CBT telephone counseling and were offered 2 weeks of nicotine replacement therapy (NRT). RESULTS:ACT participants completed more calls than CBT participants (M = 3.25 in ACT vs. 2.23 in CBT; p = .001). Regarding satisfaction, 100% of ACT participants reported their treatment was useful for quitting smoking (vs. 87% for CBT; p = .03), and 97% of ACT participants would recommend their treatment to a friend (vs. 83% for CBT; p = .06). On the primary outcome of intent-to-treat 30-day point prevalence abstinence at 6 months postrandomization, the quit rates were 31% in ACT versus 22% in CBT (odds ratio [OR] = 1.5, 95% confidence interval [CI] = 0.7-3.4). Among participants depressed at baseline (n = 47), the quit rates were 33% in ACT versus 13% in CBT (OR = 1.2, 95% CI = 1.0-1.6). Consistent with ACT's theory, among participants scoring low on acceptance of cravings at baseline (n = 57), the quit rates were 37% in ACT versus 10% in CBT (OR = 5.3, 95% CI = 1.3-22.0). CONCLUSIONS:ACT is feasible to deliver by phone, is highly acceptable to quitline callers, and shows highly promising quit rates compared with standard CBT quitline counseling. As results were limited by the pilot design (e.g., small sample), a full-scale efficacy trial is now needed.
RCT Entities:
OBJECTIVE: We conducted a pilot randomized trial of telephone-delivered acceptance and commitment therapy (ACT) versus cognitive behavioral therapy (CBT) for smoking cessation. METHOD:Participants were 121 uninsured South Carolina State Quitline callers who were adult smokers (at least 10 cigarettes/day) and who wanted to quit within the next 30 days. Participants were randomized to 5 sessions of either ACT or CBT telephone counseling and were offered 2 weeks of nicotine replacement therapy (NRT). RESULTS: ACT participants completed more calls than CBT participants (M = 3.25 in ACT vs. 2.23 in CBT; p = .001). Regarding satisfaction, 100% of ACT participants reported their treatment was useful for quitting smoking (vs. 87% for CBT; p = .03), and 97% of ACT participants would recommend their treatment to a friend (vs. 83% for CBT; p = .06). On the primary outcome of intent-to-treat 30-day point prevalence abstinence at 6 months postrandomization, the quit rates were 31% in ACT versus 22% in CBT (odds ratio [OR] = 1.5, 95% confidence interval [CI] = 0.7-3.4). Among participants depressed at baseline (n = 47), the quit rates were 33% in ACT versus 13% in CBT (OR = 1.2, 95% CI = 1.0-1.6). Consistent with ACT's theory, among participants scoring low on acceptance of cravings at baseline (n = 57), the quit rates were 37% in ACT versus 10% in CBT (OR = 5.3, 95% CI = 1.3-22.0). CONCLUSIONS: ACT is feasible to deliver by phone, is highly acceptable to quitline callers, and shows highly promising quit rates compared with standard CBT quitline counseling. As results were limited by the pilot design (e.g., small sample), a full-scale efficacy trial is now needed.
Authors: Pebbles Fagan; Gary King; Deirdre Lawrence; Sallie Anne Petrucci; Robert G Robinson; David Banks; Sharon Marable; Rachel Grana Journal: Am J Public Health Date: 2004-02 Impact factor: 9.308
Authors: Adrienne J Means-Christensen; Cathy D Sherbourne; Peter P Roy-Byrne; Michelle G Craske; Murray B Stein Journal: Gen Hosp Psychiatry Date: 2006 Mar-Apr Impact factor: 3.238
Authors: Jaimee L Heffner; Roger Vilardaga; Laina D Mercer; Julie A Kientz; Jonathan B Bricker Journal: Am J Drug Alcohol Abuse Date: 2014-11-14 Impact factor: 3.829
Authors: Emily Y Zeng; Roger Vilardaga; Jaimee L Heffner; Kristin E Mull; Jonathan B Bricker Journal: Telemed J E Health Date: 2015-07-14 Impact factor: 3.536
Authors: Sarah E Woolf-King; Alan Z Sheinfil; Jacklyn D Babowich; Bob Siedle-Khan; Amanda Loitsch; Stephen A Maisto Journal: Alcohol Treat Q Date: 2018-11-08
Authors: Tanya R Schlam; Timothy B Baker; Stevens S Smith; Jessica W Cook; Megan E Piper Journal: Nicotine Tob Res Date: 2020-01-27 Impact factor: 4.244
Authors: Jaimee L Heffner; Jennifer B McClure; Kristin E Mull; Robert M Anthenelli; Jonathan B Bricker Journal: Bipolar Disord Date: 2015-04-25 Impact factor: 6.744
Authors: Emily Y Zeng; Jaimee L Heffner; Wade K Copeland; Kristin E Mull; Jonathan B Bricker Journal: Addict Behav Date: 2016-07-08 Impact factor: 3.913